Recruiting studies: Nasopharyngeal Carcinoma By Ajcc V8 Stage

Studies currently listed as recruiting on the public registry for this search term. Each page explains the study in plain language, with locations and the study team's contact details. Clinicians: generate a printable list for your patient →

Testing the Addition of the Drug BMX-001, a Radioprotector, or a Placebo to the Usual Chemoradiation Therapy for Patient
Phase 2 · 153 location(s) · NRG Oncology · NCT06532279 CTV Delineation Based Solely on Geometric Expansion From GTV in Nasopharyngeal Carcinoma
Phase 3 · 1 location(s) · Fujian Cancer Hospital · NCT06095154 NBI Combined With MRI to Guide CTV Optimization in Eccentric Nasopharyngeal Carcinoma
NA · 1 location(s) · Chongqing University Cancer Hospital · NCT06167109 Concurrent and Adjuvant Nimotuzumab Combined With Induction Chemotherapy Plus Chemoradiation in Nasopharyngeal Carcinoma
NA · 9 location(s) · Fourth Affiliated Hospital of Guangxi Medical University · NCT05717790 Testing the Addition of BMS-986016 (Relatlimab) to the Usual Immunotherapy After Initial Treatment for Recurrent or Meta
Phase 2 · 88 location(s) · National Cancer Institute (NCI) · NCT06029270 Induction Chemotherapy Response-Guided Radiation for EBV-Associated Nasopharyngeal Carcinoma
NA · 1 location(s) · University of California, San Francisco · NCT06682442 Nimotuzumab Combined With TGP as First-line Therapy in Patients With Recurrent/Metastatic Nasopharyngeal Carcinoma
Phase 2 · 1 location(s) · Cancer Institute and Hospital, Chinese Academy of Medical Sc · NCT06509009 TMV Vaccine Therapy Alone and With Pembrolizumab for the Treatment of Recurrent and/or Metastatic Head and Neck Squamous
Phase 1 · 2 location(s) · Emory University · NCT06868433 Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radi
NA · 1 location(s) · Emory University · NCT06662058 A Study Using Nivolumab, in Combination With Chemotherapy Drugs to Treat Nasopharyngeal Carcinoma (NPC)
Phase 2 · 85 location(s) · National Cancer Institute (NCI) · NCT06064097 Blood Tests and Questionnaires in Studying Adherence to Preventative Swallowing Exercises in Participants With Metastati
Phase N/A · 1 location(s) · M.D. Anderson Cancer Center · NCT03010150 Testing Whether Cemiplimab (REGN2810) Plus CDX-1140 Given Prior to Surgery Are Better Than Cemiplimab (REGN2810) Alone i
Phase 2 · 6 location(s) · National Cancer Institute (NCI) · NCT06980038 Lovastatin and Pembrolizumab for the Treatment of Patients With Recurrent or Metastatic Head and Neck Cancer, LAPP Trial
Phase 2 · 2 location(s) · Emory University · NCT06636734

Look up another condition

Patient organization or foundation? You can brand this page for your community — your logo, your resources, same honest registry data, kept current daily. Ask about branding →

This page is independently generated by Eichor from the public ClinicalTrials.gov record and re-synced daily. It is not the sponsor's official website unless claimed. Nothing here is medical advice; eligibility is always determined by the study team — talk to your own doctor first.